Prioritization of cancer therapeutic targets using CRISPR–Cas9 screensFiona M. Behan, Mathew J. Garnett, Francesco Sassi et al.|Nature|2019Cited by 1.4k
Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screeningGabriele Picco, Mathew J. Garnett, Elisabeth Chen et al.|Nature Communications|2019Cited by 134
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and ImmunotherapyGabriele Picco, Mathew J. Garnett|Cancer Discovery|2021Cited by 113
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer CellsGabriele Picco, Mathew J. Garnett|Cancer Discovery|2024Cited by 48